Skip to content

Clinical trials

Carcinoma, Ovarian Epithelial trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Ovarian Epithelial Country / region: Czechia Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20121
20133
20142
20161
20171
20182
20191
20202
20221
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Active, not recruiting2
Recruiting2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Medical University of Vienna3
SOTIO a.s.3
ImmunoGen, Inc.2
pharmaand GmbH2
AbbVie1
Amgen1
AstraZeneca1
CanariaBio Inc.1
Daiichi Sankyo1
EBMT Solid Tumors Working Party1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Ovarian Epithelial19
Ovarian Neoplasms13
Fallopian Tube Neoplasms7
Neoplasms6
Recurrence3
Carcinoma in Situ2
Adenocarcinoma of Lung1
Blast Crisis1
Breast Neoplasms1
Burkitt Lymphoma1

Trials

Showing 76 to 19 of 19. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.